[Primary liver tumours in childhood]

D G Schreiber-Dietrich1, I Leuschner2, A Tannapfel3

  • 1Pädiatrie, Caritas-Krankenhaus, Bad Mergentheim, Germany.

Zeitschrift Fur Gastroenterologie
|November 13, 2015
PubMed

Insights

This article reviews pediatric liver tumors using histopathology and contrast-enhanced ultrasound (CEUS) features. It supports the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) registry for ultrasound contrast agents in children.

Area of Science:

  • Pediatric Radiology
  • Hepatology
  • Medical Imaging

Background:

  • Focal liver lesions exhibit varying prevalence in pediatric versus adult populations.
  • Accurate diagnosis of pediatric liver tumors is crucial for appropriate management.
  • Contrast-enhanced ultrasound (CEUS) is a valuable tool in evaluating liver lesions.

Purpose of the Study:

  • To discuss pediatric liver tumors based on histopathology and contrast-enhanced ultrasound (CEUS) features.
  • To support the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Pediatric Registry.
  • To gather data on the safety and applications of ultrasound contrast agents in pediatric patients.

Main Methods:

  • Review of histopathological criteria for pediatric liver tumors.
  • Analysis of contrast-enhanced ultrasound (CEUS) features of pediatric liver lesions.
  • Data collection through the EFSUMB Pediatric Registry.

Main Results:

  • Specific histopathological findings associated with common pediatric liver tumors.
  • Characteristic CEUS patterns differentiating various pediatric liver lesions.
  • Initial data on the safety and efficacy of ultrasound contrast agents in children.

Conclusions:

  • Histopathology and CEUS are essential for diagnosing pediatric liver tumors.
  • The EFSUMB Pediatric Registry is vital for advancing knowledge on ultrasound contrast agents in children.
  • Further data collection will refine the understanding of CEUS in pediatric liver lesion evaluation.